查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1610332

quinidine sulfate市场：按给药途径、应用和最终用户划分 - 2025-2030 年全球预测

Quinidine Sulfate Market by Route of Administration (Intravenous, Oral), Application (Arrhythmias, Malaria), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

quinidine sulfate市场2023年估值为127.9亿美元，预计2024年将达到137.4亿美元，复合年增长率为6.30%，到2030年将达到196.3亿美元。

quinidine sulfate是一种广泛用作抗心律不整药物，用于治疗某些类型的心律不整的药物。quinidine sulfate广泛用作治疗心律不整的抗心律不整药物，其用途主要用于循环系统医学，对于维持心臟的正常节律和预防与心律不整相关的併发症具有重要意义。对quinidine sulfate的需求源自于心血管疾病盛行率的增加和有效心律不整管理的需要。除了循环系统之外，其最终用途还扩展到包括医院和专科诊所在内的医疗机构，这些机构的管理是在专家的监督下进行的。推动市场成长的主要因素是心血管疾病盛行率的上升、医疗基础设施的进步以及人们对心臟健康的认识不断提高。此外，药物配方和药物传输方法的技术进步正在推动需求，并为市场参与者加强研发工作提供充足的机会。主要市场参与者可以探索创新的药物传递机制，例如缓释性，以提高治疗效果和依从性。

主要市场统计
基准年[2023] 127.9亿美元
预测年份 [2024] 137.4亿美元
预测年份 [2030] 196.3亿美元
复合年增长率（%） 6.30%

然而，市场面临一些挑战。特别是，严格的法律规范、quinidine sulfate的潜在副作用以及新替代品的可用性可能会限制其采用。监管障碍和严格的临床试验要求可以延长新产品的上市时间。此外，副作用和禁忌症可能会限制奎尼丁的使用，持续的患者监测至关重要。为了克服这些限制并抓住成长机会，公司应该投资于全面的临床研究和开发，以加强奎尼丁的安全性并探索更广泛的治疗领域的新应用。在创新方面，有潜力利用生物技术来改进配方和精准医学，以改善针对患者的治疗模式。对市场格局的回顾揭示了竞争格局，各个相关人员强调增强产品供应和策略联盟以开拓的市场。透过专注于医疗保健支出不断增加和医疗保健政策不断发展的新兴市场，公司可以最大限度地提高未来的成长前景并提高其市场占有率。

市场动态：快速发展的quinidine sulfate市场的关键市场洞察

quinidine sulfate市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心律不整和疟疾等疾病的发生率增加
    • 政府积极努力意识提升对quinidine sulfate补充品的认识
    • 推广奎尼丁静脉注射防治重症恶性疟及高寄生虫血症
  • 市场限制因素
    • 抗杀虫剂载体的可用性问题
  • 市场机会
    • quinidine sulfate核准加大研发投入
    • quinidine sulfate药物研究进展
  • 市场挑战
    • 增加使用抗心律不整药物带来的健康风险

波特五力策略工具引领quinidine sulfate市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解quinidine sulfate市场的外部影响

外部宏观环境因素在塑造quinidine sulfate市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解quinidine sulfate市场的竞争格局

对quinidine sulfate市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵硫酸quinidine sulfate市场供应商的绩效评估

FPNV 定位矩阵是评估quinidine sulfate市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了quinidine sulfate市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，quinidine sulfate市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心律不整和疟疾等疾病的发生率增加
      • 政府首选倡议，以提高大众对quinidine sulfate补充品的认识
      • 推广静脉注射奎尼丁防治重症恶性疟和高寄生虫血症
    • 抑制因素
      • 抗杀虫剂载体的可用性问题
    • 机会
      • quinidine sulfate加大药品核准与研发投入
      • quinidine sulfate药物研究进展
    • 任务
      • 增加使用抗心律不整药物带来的健康风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章quinidine sulfate市场：依给药途径

  • 静脉
  • 口服

第七章quinidine sulfate市场：依应用分类

  • 心律不整
  • 疟疾

第八章quinidine sulfate市场：依最终用户分类

  • 成人
  • 小儿科

第九章 北美、南美quinidine sulfate市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区quinidine sulfate市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲quinidine sulfate市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Apotex Corporation
  • BUCHLER GmbH
  • ChemPoint
  • Inga Laboratories P. Ltd.
  • Merck KGaA
  • Novartis AG
  • Prism Industries Private Ltd.
  • PT Sinkona Indonesia lestar
  • Vital Laboratories Pvt. Ltd.
  • VIVAN Life Sciences Pvt. Limited
Product Code: MRR-62667ADFACBE

The Quinidine Sulfate Market was valued at USD 12.79 billion in 2023, expected to reach USD 13.74 billion in 2024, and is projected to grow at a CAGR of 6.30%, to USD 19.63 billion by 2030.

Quinidine sulfate is a medication prominently used as an antiarrhythmic agent to treat certain types of irregular heartbeats. Its market encompasses the pharmaceutical sector, focusing largely on cardiology where its application is critical in maintaining normal heart rhythms and preventing complications associated with arrhythmias. The necessity for quinidine sulfate stems from the increasing prevalence of cardiovascular diseases and the need for effective arrhythmia management. Besides cardiology, its end-use scope extends to medical facilities, including hospitals and specialty clinics where it is administered under professional supervision. Market growth is primarily driven by the rising incidence of cardiovascular disorders, advancements in healthcare infrastructure, and increasing awareness about cardiac health. Further, technological strides in drug formulation and delivery methods foster demand, providing ample opportunities for market players to intensify R&D efforts. Key market players can explore innovative drug delivery mechanisms, such as sustained-release formulations, to enhance therapeutic efficacy and compliance.

KEY MARKET STATISTICS
Base Year [2023] USD 12.79 billion
Estimated Year [2024] USD 13.74 billion
Forecast Year [2030] USD 19.63 billion
CAGR (%) 6.30%

However, the market faces several challenging factors, notably stringent regulatory frameworks, potential side effects of quinidine sulfate, and the availability of newer alternatives possibly limiting its adoption. Regulatory hurdles and rigorous clinical trial requirements can extend time-to-market for new developments. Additionally, adverse reactions and contraindications might restrict quinidine's use, making the need for continuous monitoring of patients critical. To overcome these limitations and capture growth opportunities, companies should invest in comprehensive clinical research and development to enhance quinidine's safety profile and explore novel applications in broader therapeutic areas. In terms of innovation, there's potential in leveraging biotechnology to refine drug formulations or improve patient-specific treatment paradigms using precision medicine. Insights into market nature reveal a competitive landscape with various stakeholders emphasizing enhanced product offerings and strategic alliances to penetrate untapped markets. By focusing on emerging markets with rising healthcare expenditures and evolving healthcare policies, organizations can maximize future growth prospects and fortify their market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Quinidine Sulfate Market

The Quinidine Sulfate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in incidence of arrhythmia and other diseases, such as malaria
    • Favorable government initiatives for increasing awareness among people about quinidine sulfate supplements
    • Prevalence for intravenous quinidine to control severe P. Falciparum and hyperparasitemia
  • Market Restraints
    • Issues regarding availability of insecticide-resistant vectors
  • Market Opportunities
    • Increasing drug approvals and investments in R&D of quinidine sulfate
    • Advancements in quinidine sulfate drugs
  • Market Challenges
    • Health risks due to the increased use of antiarrhythmic drug

Porter's Five Forces: A Strategic Tool for Navigating the Quinidine Sulfate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Quinidine Sulfate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Quinidine Sulfate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Quinidine Sulfate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Quinidine Sulfate Market

A detailed market share analysis in the Quinidine Sulfate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Quinidine Sulfate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Quinidine Sulfate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Quinidine Sulfate Market

A strategic analysis of the Quinidine Sulfate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Quinidine Sulfate Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Corporation, BUCHLER GmbH, ChemPoint, Inga Laboratories P. Ltd., Merck KGaA, Novartis AG, Prism Industries Private Ltd., PT Sinkona Indonesia lestar, Vital Laboratories Pvt. Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Quinidine Sulfate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Intravenous and Oral.
  • Based on Application, market is studied across Arrhythmias and Malaria.
  • Based on End-User, market is studied across Adults and Pediatrics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in incidence of arrhythmia and other diseases, such as malaria
      • 5.1.1.2. Favorable government initiatives for increasing awareness among people about quinidine sulfate supplements
      • 5.1.1.3. Prevalence for intravenous quinidine to control severe P. Falciparum and hyperparasitemia
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding availability of insecticide-resistant vectors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing drug approvals and investments in R&D of quinidine sulfate
      • 5.1.3.2. Advancements in quinidine sulfate drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Health risks due to the increased use of antiarrhythmic drug
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Quinidine Sulfate Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intravenous
  • 6.3. Oral

7. Quinidine Sulfate Market, by Application

  • 7.1. Introduction
  • 7.2. Arrhythmias
  • 7.3. Malaria

8. Quinidine Sulfate Market, by End-User

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Pediatrics

9. Americas Quinidine Sulfate Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Quinidine Sulfate Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Quinidine Sulfate Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Apotex Corporation
  • 3. BUCHLER GmbH
  • 4. ChemPoint
  • 5. Inga Laboratories P. Ltd.
  • 6. Merck KGaA
  • 7. Novartis AG
  • 8. Prism Industries Private Ltd.
  • 9. PT Sinkona Indonesia lestar
  • 10. Vital Laboratories Pvt. Ltd.
  • 11. VIVAN Life Sciences Pvt. Limited

LIST OF FIGURES

  • FIGURE 1. QUINIDINE SULFATE MARKET RESEARCH PROCESS
  • FIGURE 2. QUINIDINE SULFATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL QUINIDINE SULFATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. QUINIDINE SULFATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL QUINIDINE SULFATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. QUINIDINE SULFATE MARKET DYNAMICS
  • TABLE 7. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ARRHYTHMIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2023